IL164670A0 - Pharmaceutical compositions containing growth hormone and an insulin sensitizing agent - Google Patents
Pharmaceutical compositions containing growth hormone and an insulin sensitizing agentInfo
- Publication number
- IL164670A0 IL164670A0 IL16467004A IL16467004A IL164670A0 IL 164670 A0 IL164670 A0 IL 164670A0 IL 16467004 A IL16467004 A IL 16467004A IL 16467004 A IL16467004 A IL 16467004A IL 164670 A0 IL164670 A0 IL 164670A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- growth hormone
- sensitizing agent
- containing growth
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000001235 sensitizing effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0209642A GB0209642D0 (en) | 2002-04-26 | 2002-04-26 | Metabolic syndrome |
GB0218912A GB0218912D0 (en) | 2002-08-14 | 2002-08-14 | Metabolic syndrome |
PCT/EP2003/004357 WO2003090784A1 (en) | 2002-04-26 | 2003-04-24 | Treatment of metabolic syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
IL164670A0 true IL164670A0 (en) | 2005-12-18 |
Family
ID=29272006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16467004A IL164670A0 (en) | 2002-04-26 | 2004-10-18 | Pharmaceutical compositions containing growth hormone and an insulin sensitizing agent |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1499357A1 (xx) |
JP (1) | JP2005523915A (xx) |
KR (1) | KR20040101545A (xx) |
CN (1) | CN1646167A (xx) |
AU (1) | AU2003227683A1 (xx) |
BR (1) | BR0309375A (xx) |
CA (1) | CA2483005A1 (xx) |
IL (1) | IL164670A0 (xx) |
MX (1) | MXPA04010544A (xx) |
PL (1) | PL372900A1 (xx) |
WO (1) | WO2003090784A1 (xx) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2016101363A (ru) * | 2010-02-08 | 2018-11-21 | Прэари Фармасьютикалз, Ллк | Способ лечения заболеваний, связанных с глюкокортикоидной нечувствительностью |
-
2003
- 2003-04-24 JP JP2003587413A patent/JP2005523915A/ja active Pending
- 2003-04-24 EP EP03725104A patent/EP1499357A1/en not_active Withdrawn
- 2003-04-24 CA CA002483005A patent/CA2483005A1/en not_active Abandoned
- 2003-04-24 WO PCT/EP2003/004357 patent/WO2003090784A1/en not_active Application Discontinuation
- 2003-04-24 KR KR10-2004-7016843A patent/KR20040101545A/ko not_active Application Discontinuation
- 2003-04-24 AU AU2003227683A patent/AU2003227683A1/en not_active Abandoned
- 2003-04-24 PL PL03372900A patent/PL372900A1/xx not_active Application Discontinuation
- 2003-04-24 BR BR0309375-1A patent/BR0309375A/pt not_active IP Right Cessation
- 2003-04-24 MX MXPA04010544A patent/MXPA04010544A/es active IP Right Grant
- 2003-04-24 CN CNA038088312A patent/CN1646167A/zh active Pending
-
2004
- 2004-10-18 IL IL16467004A patent/IL164670A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR20040101545A (ko) | 2004-12-02 |
CA2483005A1 (en) | 2003-11-06 |
WO2003090784A1 (en) | 2003-11-06 |
MXPA04010544A (es) | 2005-08-16 |
EP1499357A1 (en) | 2005-01-26 |
JP2005523915A (ja) | 2005-08-11 |
PL372900A1 (en) | 2005-08-08 |
BR0309375A (pt) | 2005-03-29 |
AU2003227683A1 (en) | 2003-11-10 |
CN1646167A (zh) | 2005-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1093975A1 (en) | Ppar-activating compound and pharmaceutical composition containing same | |
IL162548A0 (en) | 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same | |
AU2003266133A1 (en) | Materials and methods for drug delivery and uptake | |
IL164209A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
IL166620A0 (en) | Pyrazole derivatives and pharmaceutical compositions containing the same | |
AU2003288994A1 (en) | Nitrogen-containing heterocyclic compounds and medicinal use thereof | |
AU2003298841A1 (en) | Pharmaceutical compositions containing indistinguishable drug components | |
AU2003291024A1 (en) | Rhodanine derivatives and pharmaceutical compositions containing them | |
IL163117A (en) | Indazole derivatives and pharmaceutical compositions containing the same | |
AU2003234231A1 (en) | New polyarylates for drug delivery and tissue engineering | |
IL178297A0 (en) | Hydrazide derivatives and pharmaceutical compositions containing the same | |
HK1077582A1 (en) | Aryl 5-thio beta-d-glucopyranside derivatives and remedies for diabetes containing sthe same | |
IL163866A0 (en) | 8-Azaprostaglandin derivative compounds and drugs containing the compounds s active ingredient | |
AU2003243750A8 (en) | Rapidly dissolving micro-perforator for drug delivery and other applications | |
IL164455A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
EP1479666A4 (en) | ESTER CONNECTION AND THEIR MEDICAL USE | |
AU2003247942A1 (en) | Device and method for drug delivery to animals | |
AU2003289440A1 (en) | Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof | |
IL197889A (en) | Pyridylvinylazacyclopentane compound and pharmaceutical compositions comprising same | |
HK1082677A1 (en) | Androgen pharmaceutical composition and use for manufacture of medicament | |
AU2003279253A1 (en) | Silicone blends and composites for drug delivery | |
IL174144A0 (en) | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone | |
IL163868A (en) | Hemiasterlin derivatives and pharmaceutical compositions comprising them | |
IL176077A0 (en) | 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them | |
PL374199A1 (en) | Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone |